Human medicines European public assessment report (EPAR): Amglidia, glibenclamide, Date of authorisation: 24/05/2018, Revision: 8, Status: Authorised
Frequently asked questions on medicinal products development and assessment involving companion diagnostic (CDx)
Human medicines European public assessment report (EPAR): Laventair Ellipta (previously Laventair), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 18, Status: Authorised
Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 19, Status: Authorised
Presentation - The EU EU health policy Pharmaceutical Reform - Lilia Luchianov (DG SANTE, EC)
Guideline on specific adverse reaction follow-up questionnaires (Specific AR FUQ)
Proposed invented name(s) request form for veterinary medicinal products
Quality Review of Documents (QRD) working group plenary meeting dates
Norditropin (somatropin) supply shortage
CTIS newsflash – 24 November 2023